Key result
Total laryngectomy followed by chemo-radiotherapy for laryngeal synovial sarcoma resulted in no macroscopic signs of tumoral relapse over 2 years of follow-up.
Why the study?
Laryngeal synovial sarcoma is an extremely rare mesenchymal tumor, with under 40 cases reported in the literature over the past four decades.
Case Report (n=1)
Total laryngectomy followed by chemo-radiotherapy resulted in no macroscopic signs of tumoral relapse at 2 years in a rare case of laryngeal synovial sarcoma.
Answers are grounded in this paper and cite their sources.
Supports multimodality therapy in rare laryngeal synovial sarcoma; extends sparse reports but leaves optimal management open.
Laryngeal synovial sarcoma is an extremely rare mesenchymal tumor. During the past four decades, literature findings revealed under 40 cases with this localization. We are bringing forward the case of a 70-year-old male patient who was referred to the ENT Clinic as a respiratory emergency – a tumor obstructing the laryngeal glottis, for which an emergency tracheotomy was initially performed, followed by a CT scan and a biopsy under general anesthesia through suspension videolaringoscopy. The histopathological report was suggestive of a biphasic synovial sarcoma. A multidisciplinary team set the surgical indication for total laryngectomy followed by chemo-radiotherapy. Long-term follow-up is mandatory for recurrence prevention. Patient has checked in for follow-up every 3 months over the past 2 years, with no macroscopic signs of tumoral relapse.
No takes yet. Share an insight, caveat, or question.
Vlăescu et al. (2020) conducted a case report in Laryngeal synovial sarcoma (n=1). Total laryngectomy followed by chemo-radiotherapy was evaluated on Macroscopic signs of tumoral relapse. Total laryngectomy followed by chemo-radiotherapy for laryngeal synovial sarcoma resulted in no macroscopic signs of tumoral relapse over 2 years of follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: